Search Results

There are 241002 results for: content related to: What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

  1. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 347–368, Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi and Masatoshi Kudo

    Version of Record online : 29 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00642.x

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 59–70, Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12272

  4. You have free access to this content
    Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders

    Hepatology

    Volume 43, Issue 5, May 2006, Pages: 943–953, Andrew H. Talal, Ruy M. Ribeiro, Kimberly A. Powers, Michael Grace, Constance Cullen, Musaddeq Hussain, Marianthi Markatou and Alan S. Perelson

    Version of Record online : 20 APR 2006, DOI: 10.1002/hep.21136

  5. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Version of Record online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  6. You have free access to this content
    Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial

    Hepatology

    Volume 50, Issue 4, October 2009, Pages: 1045–1055, Stuart K. Roberts, Martin D. Weltman, Darrell H. G. Crawford, Geoffrey W. McCaughan, William Sievert, Wendy S. Cheng, William Rawlinson, Paul V. Desmond, Phillipa S. Marks, Motoko Yoshihara, Bishoy Rizkalla, Jean K. DePamphilis, Gregory J. Dore and Chariot Study Group

    Version of Record online : 15 JUN 2009, DOI: 10.1002/hep.23130

  7. You have free access to this content
    2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 2–8, Vincenza Calvaruso and Antonio Craxì

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02703.x

  8. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  9. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  10. You have free access to this content
    Optimal treatment with telaprevir for chronic HCV infection

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 3–13, Arun B. Jesudian and Ira M. Jacobson

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12079

  11. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis

    Liver International

    Volume 31, Issue 3, March 2011, Pages: 401–411, Sanaa M. Kamal, Amany Ahmed, Sara Mahmoud, Leila Nabegh, Iman El Gohary, Isi Obadan, Tamer Hafez, Dahlia Ghoraba, Ahmed A. Aziz and Mona Metaoei

    Version of Record online : 11 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02435.x

    Corrected by:

    CORRIGENDA

    Vol. 31, Issue 4, 588, Version of Record online: 17 FEB 2011

  12. Growth inhibitory effects of pegylated IFN α-2b on human liver cancer cells in vitro and in vivo

    Liver International

    Volume 26, Issue 8, October 2006, Pages: 964–975, Hirohisa Yano, Sachiko Ogasawara, Seiya Momosaki, Jun Akiba, Sakiko Kojiro, Suguru Fukahori, Hironori Ishizaki, Keitaro Kuratomi, Yuji Basaki, Shinji Oie, Michihiko Kuwano and Masamichi Kojiro

    Version of Record online : 10 AUG 2006, DOI: 10.1111/j.1478-3231.2006.01321.x

  13. You have free access to this content
    Abstracts 1072 to 1346

    Hepatology

    Volume 44, Issue S1, October 2006, Pages: 588A–691A,

    Version of Record online : 25 SEP 2006, DOI: 10.1002/hep.21399

  14. Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 21, Issue 12, December 2014, Pages: 825–834, G. L.-H. Wong, V. W.-S. Wong and H. L.-Y. Chan

    Version of Record online : 17 NOV 2014, DOI: 10.1111/jvh.12341

  15. Rapid reduction of hepatitis C virus-Core protein in the peripheral blood improve the immunological response in chronic hepatitis C patients

    Hepatology Research

    Volume 41, Issue 12, December 2011, Pages: 1153–1168, Yasuteru Kondo, Yoshiyuki Ueno, Yuta Wakui, Masashi Ninomiya, Eiji Kakazu, Jun Inoue, Koju Kobayashi, Noriyuki Obara and Tooru Shimosegawa

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00878.x

  16. Expert recommendations on the application of interferon for chronic hepatitis B

    Journal of Digestive Diseases

    Volume 14, Issue 12, December 2013, Pages: 626–637, Mo Bin Wan and Xin Hua Weng

    Version of Record online : 5 NOV 2013, DOI: 10.1111/1751-2980.12096

  17. Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin

    Journal of Viral Hepatitis

    Volume 16, Issue 8, August 2009, Pages: 578–585, T. Oze, N. Hiramatsu, T. Yakushijin, M. Kurokawa, T. Igura, K. Mochizuki, K. Imanaka, A. Yamada, M. Oshita, H. Hagiwara, E. Mita, T. Ito, Y. Inui, T. Hijioka, S. Tamura, H. Yoshihara, E. Hayashi, A. Inoue, Y. Imai, M. Kato, Y. Yoshida, T. Tatsumi, K. Ohkawa, S. Kiso, T. Kanto, A. Kasahara, T. Takehara and N. Hayashi

    Version of Record online : 22 JUN 2009, DOI: 10.1111/j.1365-2893.2009.01116.x

  18. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  19. You have free access to this content
    Pegylated interferon-α2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysers

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue 1, July 2004, Pages: 37–44, G. Barril, J. A. Quiroga, P. Sanz, F. Rodrìguez-Salvanés, R. Selgas and V. Carreño

    Version of Record online : 14 JUN 2004, DOI: 10.1111/j.1365-2036.2004.02014.x

  20. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017